1. Home
  2. GDTC vs NVNI Comparison

GDTC vs NVNI Comparison

Compare GDTC & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • NVNI
  • Stock Information
  • Founded
  • GDTC 2018
  • NVNI 2019
  • Country
  • GDTC Singapore
  • NVNI Brazil
  • Employees
  • GDTC N/A
  • NVNI N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • NVNI
  • Sector
  • GDTC Health Care
  • NVNI
  • Exchange
  • GDTC Nasdaq
  • NVNI Nasdaq
  • Market Cap
  • GDTC 28.0M
  • NVNI 31.5M
  • IPO Year
  • GDTC 2023
  • NVNI N/A
  • Fundamental
  • Price
  • GDTC $2.00
  • NVNI $0.34
  • Analyst Decision
  • GDTC Buy
  • NVNI
  • Analyst Count
  • GDTC 1
  • NVNI 0
  • Target Price
  • GDTC $5.00
  • NVNI N/A
  • AVG Volume (30 Days)
  • GDTC 7.9K
  • NVNI 1.2M
  • Earning Date
  • GDTC 01-01-0001
  • NVNI 08-07-2025
  • Dividend Yield
  • GDTC N/A
  • NVNI N/A
  • EPS Growth
  • GDTC N/A
  • NVNI N/A
  • EPS
  • GDTC N/A
  • NVNI N/A
  • Revenue
  • GDTC $368,838.00
  • NVNI $31,250,627.00
  • Revenue This Year
  • GDTC $5.37
  • NVNI $12.05
  • Revenue Next Year
  • GDTC N/A
  • NVNI $15.02
  • P/E Ratio
  • GDTC N/A
  • NVNI N/A
  • Revenue Growth
  • GDTC N/A
  • NVNI 1491.58
  • 52 Week Low
  • GDTC $1.20
  • NVNI $0.14
  • 52 Week High
  • GDTC $4.05
  • NVNI $12.19
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 40.10
  • NVNI 52.07
  • Support Level
  • GDTC $2.01
  • NVNI $0.34
  • Resistance Level
  • GDTC $2.22
  • NVNI $0.38
  • Average True Range (ATR)
  • GDTC 0.09
  • NVNI 0.03
  • MACD
  • GDTC -0.02
  • NVNI 0.01
  • Stochastic Oscillator
  • GDTC 5.88
  • NVNI 67.35

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

Share on Social Networks: